284 related articles for article (PubMed ID: 11160951)
1. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
Biton V; Levisohn P; Hoyler S; Vuong A; Hammer AE
J Child Neurol; 2003 Feb; 18(2):133-9. PubMed ID: 12693782
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
5. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
6. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
7. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Luef G; Abraham I; Trinka E; Unterberger I; Hoppichler F; Bauer G; Lechleitner M
Neurology; 2001 Aug; 57(3):565-6. PubMed ID: 11502944
[No Abstract] [Full Text] [Related]
8. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
9. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
[TBL] [Abstract][Full Text] [Related]
10. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.
Morrell MJ; Isojärvi J; Taylor AE; Dam M; Ayala R; Gomez G; O'Neill F; Tennis P; Messenheimer J
Epilepsy Res; 2003 May; 54(2-3):189-99. PubMed ID: 12837570
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Morris GL; Hammer AE; Kustra RP; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
[TBL] [Abstract][Full Text] [Related]
12. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
Machado RA; García VF; Astencio AG; Cuartas VB
Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
[TBL] [Abstract][Full Text] [Related]
14. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.
Grisotto KP; Bruck I; Antoniuk SA; Santos LH
Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703
[TBL] [Abstract][Full Text] [Related]
15. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine for the treatment of epilepsy in childhood.
Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine and valproate: efficacy of co-administration in a pediatric population.
Thomé-Souza S; Freitas A; Fiore LA; Valente KD
Pediatr Neurol; 2003 May; 28(5):360-4. PubMed ID: 12878297
[TBL] [Abstract][Full Text] [Related]
18. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
19. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
[TBL] [Abstract][Full Text] [Related]
20. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
Stephen LJ; Sills GJ; Leach JP; Butler E; Parker P; Hitiris N; Leach VM; Wilson EA; Brodie MJ
Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
